Editorial Open Access
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2024.29.45.2400729
Like 0
Access full text
Article
-
Should all hospitalised patients colonised with Candida auris be considered for isolation?
- Eelco FJ Meijer1,2 , Andreas Voss3
-
View Affiliations Hide AffiliationsAffiliations: 1 Radboudumc-CWZ Center of Expertise for Mycology, Nijmegen, the Netherlands 2 Department of Medical Microbiology and Immunology, Canisius-Wilhelmina Hospital/Dicoon, Nijmegen, the Netherlands 3 Department of Medical Microbiology and Infection Control, University Medical Center Groningen, Groningen, the NetherlandsEelco Meijereelco.meijer cwz.nl
-
View Citation Hide Citation
Citation style for this article: Meijer Eelco FJ, Voss Andreas. Should all hospitalised patients colonised with Candida auris be considered for isolation?. Euro Surveill. 2024;29(45):pii=2400729. https://doi.org/10.2807/1560-7917.ES.2024.29.45.2400729 Received: 30 Oct 2024; Accepted: 07 Nov 2024
- Previous Article
- Table of Contents
- Next Article
Preview this article:
Should all hospitalised patients colonised with Candida auris be considered for isolation?, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/eurosurveillance/29/45/eurosurv-29-45-1-1.gifThere is no abstract available.
Article metrics loading...
/content/10.2807/1560-7917.ES.2024.29.45.2400729
2024-11-07
2024-12-24
/content/10.2807/1560-7917.ES.2024.29.45.2400729
Full text loading...
/deliver/fulltext/eurosurveillance/29/45/eurosurv-29-45-1.html?itemId=/content/10.2807/1560-7917.ES.2024.29.45.2400729&mimeType=html&fmt=ahah
References
-
World Health Organization (WHO). WHO fungal priority pathogens list to guide research, development and public health action. Geneva: WHO. 25 Oct 2022. Available from: https://www.who.int/publications/i/item/9789240060241
-
World Health Organization (WHO). Global research agenda for antimicrobial resistance in human health. Geneva: WHO. 22 Jun 2023. Available from: https://www.who.int/publications/m/item/global-research-agenda-for-antimicrobial-resistance-in-human-health
-
Kenters N, Kiernan M, Chowdhary A, Denning DW, Pemán J, Saris K, et al. Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting. Int J Antimicrob Agents. 2019;54(4):400-6. https://doi.org/10.1016/j.ijantimicag.2019.08.013 PMID: 31419480
-
Rosa R, Abbo LM, Jimenez A, Carter C, Ruiz M, Gerald W, et al. Effectiveness of a sodium hypochlorite isotonic solution in decolonization of patients with Candida auris: Learnings from a county health care system. Am J Infect Control. 2024;52(5):595-8. https://doi.org/10.1016/j.ajic.2023.11.008 PMID: 38007101
-
Meletiadis J, Siopi M, Spruijtenburg B, Georgiou PC, Kostoula M, Vourli S, et al. Candida auris fungaemia outbreak in a tertiary care academic hospital and emergence of a pan-echinocandin resistant isolate, Greece, 2021 to 2023. Euro Surveill. 2024;29(45):2400128. https://doi.org/10.2807/1560-7917.ES.2024.29.45.2400128
-
Samenwerkingsverband Richtlijnen Infectiepreventie (SRI). Bijzonder resistente micro-organismen (BRMO). [Dutch Collaborative Partnership for Infection Prevention Guidelines (SRI). Multidrug-resistant organisms (MDRO)]. Bilthoven: SRI; 11 Oct 2024. Dutch. Available from: https://www.sri-richtlijnen.nl/brmo
-
European Centre for Disease Prevention and Control (ECDC). Surveillance Atlas of Infectious Diseases. Stockholm: ECDC. 28 Apr 2023. Available from: https://www.ecdc.europa.eu/en/surveillance-atlas-infectious-diseases
-
Wertheim HF, Vos MC, Boelens HA, Voss A, Vandenbroucke-Grauls CM, Meester MH, et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect. 2004;56(4):321-5. https://doi.org/10.1016/j.jhin.2004.01.026 PMID: 15066745
-
Overdevest I, Nijs M, Op den Buijs I, van Dommelen L, Fonville J. Optimalisatie van screening op carbapenemase-producerende Enterobacteriaceae. [Screening optimalisation for Carbapenemase-producing Enterobacterales]. Ned Tijdschr Med Microbiol. 2019;272Dutch. Available from: https://www.nvmm.nl/ntmm/artikeloverzicht/juni-2019
-
Samenwerkingsverband Richtlijnen Infectiepreventie (SRI). Conceptrichtlijn 10 Infectiepreventie Bijzonder Resistente MicroOrganismen (BRMO). [Dutch Collaborative Partnership for Infection Prevention Guidelines (SRI). Concept guideline 10 infection prevention multidrug-resistant organisms (MDRO)]. Bilthoven: SRI. [Accessed: 25 Jul 2024]. Dutch. Available from: https://www.nvmm.nl/media/5032/conceptrichtlijn-infectiepreventie-bijzonder-resistente-micro-organismen-brmo-_def-versie-3.pdf
-
Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis. 2017;64(2):134-40. https://doi.org/10.1093/cid/ciw691 PMID: 27988485
-
Spruijtenburg B, Ahmad S, Asadzadeh M, Alfouzan W, Al-Obaid I, Mokaddas E, et al. Whole genome sequencing analysis demonstrates therapy-induced echinocandin resistance in Candida auris isolates. Mycoses. 2023;66(12):1079-86. https://doi.org/10.1111/myc.13655 PMID: 37712885
-
Carolus H, Pierson S, Muñoz JF, Subotić A, Cruz RB, Cuomo CA, et al. Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance. MBio. 2021;12(2):e03333-20. https://doi.org/10.1128/mBio.03333-20 PMID: 33820824
-
Rybak JM, Barker KS, Muñoz JF, Parker JE, Ahmad S, Mokaddas E, et al. In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris. Clin Microbiol Infect. 2022;28(6):838-43. https://doi.org/10.1016/j.cmi.2021.11.024 PMID: 34915074
-
Cadnum JL, Shaikh AA, Piedrahita CT, Sankar T, Jencson AL, Larkin EL, et al. Effectiveness of Disinfectants Against Candida auris and Other Candida Species. Infect Control Hosp Epidemiol. 2017;38(10):1240-3. https://doi.org/10.1017/ice.2017.162 PMID: 28793937
-
Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface. J Clin Microbiol. 2017;55(10):2996-3005. https://doi.org/10.1128/JCM.00921-17 PMID: 28747370
-
Daneshnia F, de Almeida Júnior JN, Ilkit M, Lombardi L, Perry AM, Gao M, et al. Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap. Lancet Microbe. 2023;4(6):e470-80. https://doi.org/10.1016/S2666-5247(23)00067-8 PMID: 37121240
-
Sansom SE, Gussin GM, Schoeny M, Singh RD, Adil H, Bell P, et al. Rapid Environmental Contamination With Candida auris and Multidrug-Resistant Bacterial Pathogens Near Colonized Patients. Clin Infect Dis. 2024;78(5):1276-84. https://doi.org/10.1093/cid/ciad752 PMID: 38059527
-
Spruijtenburg B, Nobrega de Almeida Júnior J, Ribeiro FC, Kemmerich KK, Baeta K, Meijer EFJ, et al. Multicenter Candida auris outbreak caused by azole-susceptible clade IV in Pernambuco, Brazil. Mycoses. 2024;67(6):e13752. https://doi.org/10.1111/myc.13752 PMID: 38880933
-
Leonhard SE, Chong GM, Foudraine DE, Bode LGM, Croughs P, Popping S, et al. Proposal for a screening protocol for Candida auris colonization. J Hosp Infect. 2024;146:31-6. https://doi.org/10.1016/j.jhin.2023.12.019 PMID: 38286238
-
Centers for Disease Control and Prevention (CDC). C. auris Screening: Patient Swab Collection. Atlanta: CDC; 24 Apr 2024. Available from: https://www.cdc.gov/candida-auris/hcp/screening-hcp/c-auris-screening-patient-swab-collection-1.html
-
Spruijtenburg B, Badali H, Abastabar M, Mirhendi H, Khodavaisy S, Sharifisooraki J, et al. Confirmation of fifth Candida auris clade by whole genome sequencing. Emerg Microbes Infect. 2022;11(1):2405-11. https://doi.org/10.1080/22221751.2022.2125349 PMID: 36154919
-
Khan T, Faysal NI, Hossain MM, Mah-E-Muneer S, Haider A, Moon SB, et al. Emergence of the novel sixth Candida auris Clade VI in Bangladesh. Microbiol Spectr. 2024;12(7):e0354023. https://doi.org/10.1128/spectrum.03540-23 PMID: 38842332
-
Meijer EFJ, Voss A, Meis JF. Candida auris: huidige inzichten. [Candida auris: current insights]. Ned Tijdschr Med Microbiol. 2022;302Dutch. Available from: https://www.nvmm.nl/media/4649/19962-061.pdf
-
Alfouzan W, Ahmad S, Dhar R, Asadzadeh M, Almerdasi N, Abdo NM, et al. Molecular Epidemiology of Candida Auris Outbreak in a Major Secondary-Care Hospital in Kuwait. J Fungi (Basel). 2020;6(4):307. https://doi.org/10.3390/jof6040307 PMID: 33233388
-
Hoenigl M, Salmanton-García J, Egger M, Gangneux JP, Bicanic T, Arikan-Akdagli S, et al. Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study. Lancet Infect Dis. 2023;23(6):751-61. https://doi.org/10.1016/S1473-3099(22)00872-6 PMID: 37254300
-
Kohlenberg A, Monnet DL, Plachouras D, Candida auris survey collaborative group, Candida auris survey collaborative group includes the following national experts. Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021. Euro Surveill. 2022;27(46):2200846. https://doi.org/10.2807/1560-7917.ES.2022.27.46.2200846 PMID: 36398575
-
Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5(1):35. https://doi.org/10.1186/s13756-016-0132-5 PMID: 27777756
-
Taori SK, Khonyongwa K, Hayden I, Athukorala GDA, Letters A, Fife A, et al. Candida auris outbreak: Mortality, interventions and cost of sustaining control. J Infect. 2019;79(6):601-11. https://doi.org/10.1016/j.jinf.2019.09.007 PMID: 31557493
Submit comment
Close
Comment moderation successfully completed